{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:37:11Z","timestamp":1766774231152,"version":"3.48.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"DOI":"10.7759\/cureus.100139","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:36:06Z","timestamp":1766774166000},"source":"Crossref","is-referenced-by-count":0,"title":["Thrombotic Storm: A Challenging Case of Catastrophic Antiphospholipid Syndrome"],"prefix":"10.7759","author":[{"given":"Ana Filipa","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindora","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\"","volume":"32","author":"Cervera R","year":"2009","unstructured":"Cervera R, Bucciarelli S, Plas\u00edn MA, et al.. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\". J Autoimmun. 2009, 32:240-5. 10.1016\/j.jaut.2009.02.008","journal-title":"J Autoimmun"},{"key":"ref2","article-title":"The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus","volume":"34","author":"Bayraktar UD","year":"2007","unstructured":"Bayraktar UD, Erkan D, Bucciarelli S, Espinosa G, Asherson R. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol. 2007, 34:346-52.","journal-title":"J Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.22018","article-title":"Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients","volume":"54","author":"Bucciarelli S","year":"2006","unstructured":"Bucciarelli S, Espinosa G, Cervera R, et al.. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006, 54:2568-76. 10.1002\/art.22018","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.10.018","article-title":"Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group","volume":"124","author":"Kitchens CS","year":"2011","unstructured":"Kitchens CS, Erkan D, Brand\u00e3o LR, et al.. Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group. Am J Med. 2011, 124:290-6. 10.1016\/j.amjmed.2010.10.018","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15082","article-title":"Antiphospholipid syndrome: complement activation, complement gene mutations, and therapeutic implications","volume":"19","author":"Chaturvedi S","year":"2021","unstructured":"Chaturvedi S, Braunstein EM, Brodsky RA. Antiphospholipid syndrome: complement activation, complement gene mutations, and therapeutic implications. J Thromb Haemost. 2021, 19:607-16. 10.1111\/jth.15082","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003863","article-title":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS","volume":"135","author":"Chaturvedi S","year":"2020","unstructured":"Chaturvedi S, Braunstein EM, Yuan X, et al.. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. Blood. 2020, 135:239-51. 10.1182\/blood.2019003863","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.02.007","article-title":"Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients","volume":"21","author":"Stammler R","year":"2023","unstructured":"Stammler R, Nguyen Y, Yelnik C, et al.. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients. J Thromb Haemost. 2023, 21:1258-65. 10.1016\/j.jtha.2023.02.007","journal-title":"J Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou MG","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019, 78:1296-304. 10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson RA","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, et al.. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003, 12:530-4. 10.1191\/0961203303lu394oa","journal-title":"Lupus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya M","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al.. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023, 82:1258-70. 10.1136\/ard-2023-224609","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key082","article-title":"The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients","volume":"57","author":"Rodr\u00edguez-Pint\u00f3 I","year":"2018","unstructured":"Rodr\u00edguez-Pint\u00f3 I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R. The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients. Rheumatology (Oxford). 2018, 57:1264-70. 10.1093\/rheumatology\/key082","journal-title":"Rheumatology (Oxford)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320951260","article-title":"16th International Congress on Antiphospholipid Antibodies task force report on catastrophic antiphospholipid syndrome","volume":"29","author":"Cervera R","year":"2020","unstructured":"Cervera R, Rodr\u00edguez-Pint\u00f3 I, Legault K, Erkan D. 16th International Congress on Antiphospholipid Antibodies task force report on catastrophic antiphospholipid syndrome. Lupus. 2020, 29:1594-600. 10.1177\/0961203320951260","journal-title":"Lupus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5414\/cnp70077","article-title":"Predictable removal of anticardiolipin antibody by therapeutic plasma exchange (TPE) in catastrophic antiphospholipid antibody syndrome (CAPS)","volume":"70","author":"Zar T","year":"2008","unstructured":"Zar T, Kaplan AA. Predictable removal of anticardiolipin antibody by therapeutic plasma exchange (TPE) in catastrophic antiphospholipid antibody syndrome (CAPS). Clin Nephrol. 2008, 70:77-81. 10.5414\/cnp70077","journal-title":"Clin Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.6.530","article-title":"Long term outcome of catastrophic antiphospholipid syndrome survivors","volume":"62","author":"Erkan D","year":"2003","unstructured":"Erkan D, Asherson RA, Espinosa G, Cervera R, Font J, Piette JC, Lockshin MD. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis. 2003, 62:530-3. 10.1136\/ard.62.6.530","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402340-thrombotic-storm-a-challenging-case-of-catastrophic-antiphospholipid-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:36:07Z","timestamp":1766774167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402340-thrombotic-storm-a-challenging-case-of-catastrophic-antiphospholipid-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.100139","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}